THE MIXED EPIDERMAL-CELL LYMPHOCYTE-REACTION IS THE MOST PREDICTIVE FACTOR OF ACUTE GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW GRAFT RECIPIENTS

被引：20
作者：
BAGOT, M
MARY, JY
HESLAN, M
KUENTZ, M
CORDONNIER, C
VERNANT, JP
DUBERTRET, L
LEVY, JP
机构：
[1] UNIV PARIS 07,UNITE RECH BIOMATH & BIOSTAT,INSERM,U263,F-75221 PARIS 05,FRANCE
[2] HOP HENRI MONDOR,UNITE GREFFES MOELLE,F-94010 CRETEIL,FRANCE
[3] HOP COCHIN,IMMUNOL & VIROL TUMEURS,INSERM,U152,F-75674 PARIS 14,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1988年 / 70卷 / 04期
关键词：
D O I：
10.1111/j.1365-2141.1988.tb02508.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：403 / 409
页数：7
相关论文
共 26 条
[11]  
JENICEK M, 1982, EPIDEMIOLOGIE PRINCI, P160
[12]   LETHAL GVHD ACROSS MINOR HISTOCOMPATIBILITY BARRIERS - NATURE OF THE EFFECTOR-CELLS AND ROLE OF THE H-2-COMPLEX [J].
KORNGOLD, R ;
SPRENT, J .
IMMUNOLOGICAL REVIEWS, 1983, 71 :5-29
[13]   ESTIMATION OF ERROR RATES IN DISCRIMINANT ANALYSIS [J].
LACHENBR.PA ;
MICKEY, MR .
TECHNOMETRICS, 1968, 10 (01) :1-&
[14]  
MARANINCHI D, 1987, LANCET, V2, P175
[15]  
MARTIN PJ, 1985, BLOOD, V66, P664
[16]  
MATHE G, 1979, TRANSPLANT P, V11, P235
[17]   TREATMENT OF DONOR BONE-MARROW WITH MONOCLONAL ANTI-T-CELL ANTIBODY AND COMPLEMENT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL [J].
MITSUYASU, RT ;
CHAMPLIN, RE ;
GALE, RP ;
HO, WG ;
LENARSKY, C ;
WINSTON, D ;
SELCH, M ;
ELASHOFF, R ;
GIORGI, JV ;
WELLS, J ;
TERASAKI, P ;
BILLING, R ;
FEIG, S .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) :20-26
[18]  
MORRISON DF, 1976, MULTIVARIATE STATIST, P230
[19]  
RINGDEN O, 1985, TRANSPLANT P, V17, P475
[20]  
Siegel S, 1956, FISHERS EXACT PROBAB, P96
123